共 50 条
- [41] Efficacy and safety of single- and repeated-selurampanel dosing for 2 weeks in patients with chronic subjective tinnitus: Results of a randomized, double-blind, placebo-controlled, cross-over, proof-of-concept phase IIa studyTINNITUS - AN INTERDISCIPLINARY APPROACH TOWARDS INDIVIDUALIZED TREATMENT: FROM HETEROGENEITY TO PERSONALIZED MEDICINE, 2021, 260 : 423 - 440Kucher, KlausJohns, DonaldWagner, FrankAbd-Elaziz, KhalidDerne, CarolineSverdlov, OleksandrPfister, Christian U.Langguth, Berthold
- [42] Efficacy, safety, and tolerability of IB-MS versus placebo in patients with progressive forms of MS: Preliminary results from a phase II, randomized, placebo-controlled, double blind, proof-of-concept studyMULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 168 - 168Ciampi, EthelHancke, JuanBurgos, RafaelVasquez, MacarenaReyes, AnaReyes, DiegoPinto, CarmenCarcamo, Claudia
- [43] Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trialBRAIN RESEARCH BULLETIN, 2024, 216Mohammad, Tavgah Ahmed MerzaMohammad, Talar Ahmed MerzaShawis, Teshk Nouri
- [44] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)ALLERGOLOGIE, 2024, 47 (09)Han, J. K.Li, T.Jagadeesh, S.Almqvist, G.McLaren, J.Colice, G.Megally, A.Pfaar, O.Ponnarambil, S.Lipworth, B. J.
- [45] Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study (vol 189, pg 33, 2023)BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : E81 - E81Landis, Megan N.Smith, Stacy R.Berstein, GabrielFetterly, GeraldGhosh, PranabFeng, GangPradhan, VivekAggarwal, SudeeptaBanfield, ChristopherPeeva, ElenaVincent, Michael S.Beebe, Jean S.Tarabar, Sanela
- [46] The efficacy and safety of Hanslim for obese patients Study protocol for a multicenter, randomized, double-blind, multi-dose, placebo-controlled, phase IIb clinical trialMEDICINE, 2018, 97 (38)Lee, SeunghoonLee, HyeonhoonCho, YeeunKim, JihyeKang, Jung WonSeo, Byung-KwanBaek, Yong-HyeonLee, Jae-Dong
- [47] A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failureJOURNAL OF ETHNOPHARMACOLOGY, 2016, 186 : 136 - 142Xian, ShaoxiangYang, ZhongqiLee, JunJiang, ZhipingYe, XiaohanLuo, LuyiJin, LiliYang, TianlunYe, SuilinLu, Dongfeng
- [48] Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled studyBMC NEUROLOGY, 2023, 23 (01)Yu, ShengyuanZhou, JiyingLuo, GuogangXiao, ZhemanEttrup, AndersJansson, GaryFlorea, IoanaRanc, KristinaPozo-Rosich, Patricia
- [49] Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled studyBMC Neurology, 23Shengyuan YuJiying ZhouGuogang LuoZheman XiaoAnders EttrupGary JanssonIoana FloreaKristina RancPatricia Pozo-Rosich
- [50] Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants: A Randomized, Double-Blind, Placebo-Controlled Study in Adult Patients With Major Depressive DisorderJOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (03) : 371 - +Durgam, SureshEarley, WillieGuo, HuaLi, DayongNemeth, GyorgyLaszlovszky, IstvanFava, MaurizioMontgomery, Stuart A.